COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine

• Epidemiological studies conclude diabetes to be a leading comorbidity of COVID-19. • ACE2 polymorphisms in host can influence SARS-CoV-2 susceptibility or resistance. • The in-silico data need to be corroborated with in-vivo results. • Telemedicine can bring a new change in diabetes care.

Détails bibliographiques
Publié dans:	A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.]
Auteur principal:	Sayed, Shomoita (Auteur)
Format:	Article en ligne
Langue:	English
Publié:	2021
Accès à la collection:	A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
Sujets:	hDPP4 CORONADO T1D SARS-CoV TEDDY DM MERS-CoV CFR COVID-19 DPP4 plus... SARS-CoV-2 S SNP RBD SDCC ACEI DKA HbA1c ISPAD ACE GLP-1 T2D SARS H1N1 ACE2 ARB CD26 MERS
Description matérielle:	6


LEADER	01000caa a22002652 4500
001	ELV052596885
003	DE-627
005	20230624184846.0
007	cr uuu---uuuuu
008	210910s2021 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1016/j.pcd.2020.08.018 \|2 doi
028	5	2	\|a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001249.pica
035			\|a (DE-627)ELV052596885
035			\|a (ELSEVIER)S1751-9918(20)30254-0
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 630 \|q VZ
082	0	4	\|a 640 \|q VZ
082	0	4	\|a 590 \|q VZ
082	0	4	\|a 610 \|q VZ
082	0	4	\|a 600 \|q VZ
084			\|a 50.70 \|2 bkl
100	1		\|a Sayed, Shomoita \|e verfasserin \|4 aut
245	1	0	\|a COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine
264		1	\|c 2021
300			\|a 6
336			\|a nicht spezifiziert \|b zzz \|2 rdacontent
337			\|a nicht spezifiziert \|b z \|2 rdamedia
338			\|a nicht spezifiziert \|b zu \|2 rdacarrier
520			\|a • Epidemiological studies conclude diabetes to be a leading comorbidity of COVID-19. • ACE2 polymorphisms in host can influence SARS-CoV-2 susceptibility or resistance. • The in-silico data need to be corroborated with in-vivo results. • Telemedicine can bring a new change in diabetes care.
650		7	\|a hDPP4 \|2 Elsevier
650		7	\|a CORONADO \|2 Elsevier
650		7	\|a T1D \|2 Elsevier
650		7	\|a SARS-CoV \|2 Elsevier
650		7	\|a TEDDY \|2 Elsevier
650		7	\|a DM \|2 Elsevier
650		7	\|a MERS-CoV \|2 Elsevier
650		7	\|a CFR \|2 Elsevier
650		7	\|a COVID-19 \|2 Elsevier
650		7	\|a DPP4 \|2 Elsevier
650		7	\|a SARS-CoV-2 \|2 Elsevier
650		7	\|a S \|2 Elsevier
650		7	\|a SNP \|2 Elsevier
650		7	\|a RBD \|2 Elsevier
650		7	\|a SDCC \|2 Elsevier
650		7	\|a ACEI \|2 Elsevier
650		7	\|a DKA \|2 Elsevier
650		7	\|a HbA1c \|2 Elsevier
650		7	\|a ISPAD \|2 Elsevier
650		7	\|a ACE \|2 Elsevier
650		7	\|a GLP-1 \|2 Elsevier
650		7	\|a T2D \|2 Elsevier
650		7	\|a SARS \|2 Elsevier
650		7	\|a H1N1 \|2 Elsevier
650		7	\|a ACE2 \|2 Elsevier
650		7	\|a ARB \|2 Elsevier
650		7	\|a CD26 \|2 Elsevier
650		7	\|a MERS \|2 Elsevier
773	0	8	\|i Enthalten in \|n Elsevier \|a David, Lauren A. ELSEVIER \|t A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients \|d 2016 \|g Amsterdam [u.a.] \|w (DE-627)ELV024210129
773	1	8	\|g volume:15 \|g year:2021 \|g number:1 \|g pages:4-9 \|g extent:6
856	4	0	\|u https://doi.org/10.1016/j.pcd.2020.08.018 \|3 Volltext
912			\|a GBV_USEFLAG_U
912			\|a GBV_ELV
912			\|a SYSFLAG_U
912			\|a GBV_ILN_24
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_72
912			\|a GBV_ILN_227
912			\|a GBV_ILN_350
936	b	k	\|a 50.70 \|j Energie: Allgemeines \|q VZ
951			\|a AR
952			\|d 15 \|j 2021 \|e 1 \|h 4-9 \|g 6